Fig. 3

Preparation and characterization of SHIFT&nanoICG. A Schematic of SHIFT&nanoICG preparation via SHIFT for clinical diagnosis and treatment. B Clinical drug samples prepared for TAE treatment. C Photograph of the centrifuged formulation. D Photograph of SHIFT&nanoICG freshly prepared and stored for 30 days. E Viscosity of lipiodol, RL&nanoICG, and SHIFT&nanoICG. F CT capacities of lipiodol, RL&nanoICG, and SHIFT&nanoICG